Daiichi Sankyo is the second largest pharma company in Japan, developing small molecules & biologics for various diseases and was came into existence in 2005, through the merger of Sankyo Co., Ltd. and Daiichi Pharmaceutical Co., Ltd.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
